Patent US4180670A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4180670A Expired / Lapsed US ⏱️ 0.0 years remaining

Amino pyridine derivatives

Assignee: John Wyeth and Brother Ltd
•
Filing: 1978-01-30
•
Granted: 1979-12-25
•
Expires: 1998-01-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel 4-pyridinamine derivatives having the formula ##STR1## [where R 1 and R 2 are aryl or heteroaryl (optionally linked together by a lower alkylene bridge) or one of R 1 and R 2 is aryl or heteroaryl and the other of R 1 and R 2 is lower alkyl or ar(lower)alkyl, R 3 and R 4 are each hydrogen or lower alkyl and n is 0 or 1] and their non-toxic acid addition salts are described. They show CNS activity and may be used as antidepressant drugs. Some also show stimulant activity. Novel intermediates having the formula ##STR2## are also described.

Inventors

  • 👤 Edwin T. Edington
  • 👤 Alan C. White

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 09:32
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/60; C07D213/72; C07D213/74; C07D213/75

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 106 words
A compound selected from those having the formula ##STR18## and their pharmaceutically acceptable acid addition salts, wherein one of R 1 and R 2 is selected from phenyl; naphthyl; phenyl substituted by one or two substituents selected from halogen, lower alkyl, lower alkoxy, lower alkylenedioxy and trifluoromethyl; thienyl; and pyridyl and the other one of R 1 and R 2 is selected from phenyl; naphthyl; phenyl substituted by one or two substituents selected from halogen, lower alkyl, lower alkoxy, lower alkylenedioxy, trifluoromethyl; thienyl; and pyridyl R 3 and R 4 are independently selected from hydrogen and lower alkyl and n is selected from 0 and 1.
Claim 2
Dependent Claim 106 words
A compound selected from those having the formula ##STR18## and their pharmaceutically acceptable acid addition salts, wherein one of R 1 and R 2 is selected from phenyl; naphthyl; phenyl substituted by one or two substituents selected from halogen, lower alkyl, lower alkoxy, lower alkylenedioxy and trifluoromethyl; thienyl; and pyridyl and the other one of R 1 and R 2 is selected from phenyl; naphthyl; phenyl substituted by one or two substituents selected from halogen, lower alkyl, lower alkoxy, lower alkylenedioxy, trifluoromethyl; thienyl; and pyridyl R 3 and R 4 are independently selected from hydrogen and lower alkyl and n is selected from 0 and 1.
Claim 3
Dependent Claim 19 words
A compound as defined in claim 1, which is selected from N-(diphenylmethyl)-4-pyridinamine and its pharmaceutically acceptable acid addition salts.
Claim 4
Dependent Claim 19 words
A compound as defined in claim 1, which is selected from N-[(di-p-fluorophenyl)methyl]-4-pyridinamine and its pharmaceutically acceptable acid addition salts.
Claim 5
Dependent Claim 19 words
A compound as defined in claim 1, which is selected from N-[α-(2-methylphenyl)benzyl]-4-pyridinamine and its pharmaceutically acceptable acid addition salts.
Claim 6
Dependent Claim 19 words
A compound as defined in claim 1, which is selected from N-[α-(2-thienyl)benzyl]-4-pyridinamine and its pharmaceutically acceptable acid addition salts.
Claim 7
Dependent Claim 19 words
A compound as defined in claim 1, which is selected from N-[α-(2-methoxyphenyl)benzyl]-4-pyridinamine and its pharmaceutically acceptable acid addition salts.
Claim 8
Dependent Claim 19 words
A compound as defined in claim 1, which is selected from N-[α-(2-pyridyl)benzyl]-4-pyridinamine and its pharmaceutically acceptable acid addition salts.
Claim 9
Dependent Claim 19 words
A compound as defined in claim 1, which is selected from N-(2,2-diphenylethyl)-4-pyridinamine and its pharmaceutically acceptable acid addition salts.
Claim 10
Dependent Claim 19 words
A compound as defined in claim 1 which is selected from N-(diphenylmethyl)-N-methyl-4-pyridinamine and its pharmaceutically acceptable acid addition salts.

References Cited (Backward Citations)

US2974139A Cited
US3926611A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-12-24 1983-06-25 1983-12-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-12-24 1987-06-25 1987-12-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-12-24 1991-06-25 1991-12-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag